Literature DB >> 1704424

Fatty acid composition of human myelin proteolipid protein in peroxisomal disorders.

O A Bizzozero1, G Zuñiga, M B Lees.   

Abstract

Myelin proteolipid protein (PLP) is an acylated protein which contains approximately 2 mol of ester-bound fatty acids. In this study, the amount and composition of fatty acids covalently bound to human myelin PLP were determined during development and in peroxisomal disorders. Palmitic, oleic, and stearic acids accounted for most of the PLP acyl chains. However, in contrast to PLP in other species, human PLP contains relatively more very long chain fatty acids (VLCFA). The fatty acid composition remained essentially unchanged between 1 day and 74 years of age. The total amount of fatty acid bound to PLP was not altered in any of the pathological cases examined. However, in the peroxisomal disorder adrenoleukodystrophy, the proportions of saturated and, to a lesser extent, monounsaturated VLCFA bound to PLP were increased at the expense of oleic acid. Smaller, but significant, changes were observed in adrenomyeloneuropathy. The reduction in the levels of oleic acid was also observed in two other peroxisomal disorders, the cerebrohepatorenal (Zellweger) syndrome and neonatal adrenoleukodystrophy, as well as in the lysosomal disorder Krabbe globoid cell leukodystrophy. However, in these disorders, the decrease in oleic acid occurred at the expense of stearic acid, and not VLCFA. The results indicate that, although a characteristic PLP fatty acid pattern is normally maintained, changes in the acyl chain pool can ultimately be reflected in the fatty acid composition of the protein. The altered PLP-acyl chain pattern in peroxisomal disorders may contribute to the pathophysiology of these devastating disorders.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704424     DOI: 10.1111/j.1471-4159.1991.tb02003.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

Review 1.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

2.  Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.

Authors:  H Fukaura; S C Kent; M J Pietrusewicz; S J Khoury; H L Weiner; D A Hafler
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Conserved fatty acid composition of proteolipid protein during brain development and in myelin subfractions.

Authors:  A M Messier; O A Bizzozero
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

4.  Overview: protein palmitoylation in the nervous system: current views and unsolved problems.

Authors:  O A Bizzozero; S U Tetzloff; M Bharadwaj
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

5.  Anti-ganglioside antibodies bind with enhanced affinity to gangliosides containing very long chain fatty acids.

Authors:  Yumi Tagawa; Wouter Laroy; Leonardo Nimrichter; Susan E Fromholt; Ann B Moser; Hugo W Moser; Ronald L Schnaar
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

6.  Fatty acid composition of myelin proteolipid protein during vertebrate evolution.

Authors:  O A Bizzozero; M B Lees
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 7.  Very long chain fatty acids in higher animals--a review.

Authors:  A Poulos
Journal:  Lipids       Date:  1995-01       Impact factor: 1.880

Review 8.  "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.

Authors:  Hugo W Moser; Ann B Moser; Kim Hollandsworth; N Hong Brereton; Gerald V Raymond
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

9.  Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy.

Authors:  J K Ho; H Moser; Y Kishimoto; J A Hamilton
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

10.  X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.

Authors:  Franziska D Weber; Christoph Wiesinger; Sonja Forss-Petter; Günther Regelsberger; Angelika Einwich; Willi H A Weber; Wolfgang Köhler; Hannes Stockinger; Johannes Berger
Journal:  Hum Mol Genet       Date:  2013-12-20       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.